Related Experiment Videos
Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation
M G Juarranz1, G Bodega, J C Prieto
1Molecular Neuroendocrinology Unit, Department of Biochemistry and Molecular Biology, University of Alcalá, Alcalá de Henares, Spain.
The Prostate
|June 9, 2001
Summary
Vasoactive intestinal peptide (VIP) significantly boosts rat prostate cell proliferation by activating cyclic AMP (cAMP) signaling. This study highlights VIP
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Androgens are crucial for prostate growth and function.
- Neuroendocrine peptides, like vasoactive intestinal peptide (VIP), also regulate prostate physiology.
- VIP interacts with VPAC(1) and VPAC(2) receptors, and is implicated in prostate development.
Purpose of the Study:
- To investigate the effects of VIP on the proliferation of rat prostatic epithelial cells in culture.
- To explore the signaling pathways involved in VIP-mediated prostatic cell growth.
Main Methods:
- Rat prostatic epithelial cells were cultured and characterized using cytokeratin and vimentin markers.
- [(3)H]-thymidine uptake was measured to assess cell proliferation.
- The impact of VIP and PACAP-27 on cyclic AMP (cAMP) and inositol phosphate (IPs) signaling pathways was evaluated.
Main Results:
- VIP and PACAP-27 increased cAMP production, suggesting VPAC(1) and/or VPAC(2) receptor expression.
- VIP demonstrated a bimodal increase in prostatic cell proliferation, correlating with cAMP levels.
- Inositol phosphate production was not significantly affected by VIP or PACAP-27.
Conclusions:
- VIP enhances [(3)H]thymidine uptake in cultured rat prostatic epithelial cells.
- This proliferation is likely mediated by the activation of the adenylate cyclase pathway.
- VIP plays a significant role in regulating prostatic cell proliferation through a cAMP-dependent mechanism.